Widman Fredrik sold $2.4M of ISRG

Widman Fredrik (VP Corporate Controller) sold 5,448 shares of INTUITIVE SURGICAL INC (ISRG) at $436.06 ($2.38M total) on 2026-10-30 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Widman Fredrik
Published Nov 2, 2026, 7:53 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 2, 2026, 7:58 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ISRG
Bearish
medium confidence
Mentioned
$ISRG
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ISRGBearishLow
01

Why it matters

The disclosed sale adds short‑term selling pressure but is unlikely to affect long‑term fundamentals.

02

Market read

A senior insider sold a $2.4 M stake, providing a modest bearish cue for ISRG.

03

What to watch

The 10b5‑1 plan may have been set before any material news, limiting the informational value of the sale.

Relevance 5/10Novelty 4/10Timing: after‑hours filing on 2026‑11‑02

Background

SEC Form 4 filing discloses insider transactions required by regulation.

Company-level read

Ticker impact

$ISRGBearishMedium confidence
Context

VP Corporate Controller Widman Fredrik sold 5,448 shares for $2.38M via a 10b5‑1 plan, reducing his holding to 1,026 shares.

Expected impact

likely pressure as the market prices in the insider sell

Evidence & confidence

A senior officer sold a multi‑million‑dollar stake, which typically signals reduced confidence and can trigger short‑term downside.

Market effects

Minimal impact on the broader medical‑device sector; the sale is company‑specific.

U.S. market only; no regional ripple effect.

Low; the filing is a routine insider transaction.

Counterpoint

The sale could be a routine portfolio rebalancing under a pre‑arranged plan, not a bearish signal.

Key entities

  • Intuitive Surgical Inc.

    Medical‑device maker specializing in robotic surgery systems.

  • Widman Fredrik

    Vice President, Corporate Controller at Intuitive Surgical.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ISRGMedAI 8/10

Intuitive’s US da Vinci procedure growth slows again

Intuitive Surgical reported Q3 revenue of $3.05B, up 22% YoY, with net income of $523M. U.S. da Vinci procedure growth slowed to 10%, the lowest since the pandemic. CEO David Rosa cited adoption challenges in benign general surgery. The company cut instrument prices to boost adoption in high-volume procedures, reducing near-term revenue per procedure. Intuitive adjusted its 2026 da Vinci procedure growth forecast to 14-15%.